Skip to main content
Top
Published in: European Journal of Pediatrics 2/2012

01-02-2012 | Case Report

A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5

Authors: Takayuki Okamoto, Toshihiro Tajima, Tomoya Hirayama, Satoshi Sasaki

Published in: European Journal of Pediatrics | Issue 2/2012

Login to get access

Abstract

Dent disease is an X-linked tubulopathy mainly caused by inactivating mutations of CLCN5. Features of Bartter syndrome such as hypokalemic metabolic alkalosis are rarely observed in patients with Dent disease. We report a Japanese male patient with Dent disease who also manifested features of Bartter syndrome. At the age of 3 years, he was diagnosed with Dent disease based on low molecular weight proteinuria and hypercalciuria. One year later, he was found to have features of Bartter syndrome, i.e., hypokalemia and metabolic alkalosis, and high levels of plasma renin activity and aldosterone with a normal blood pressure. Despite medical interventions, he developed chronic kidney disease stage 3 at the age of 21 years. To investigate the molecular basis of his disease, CLCN5, KCNJ1, SLC12A1, and CLCkb were analyzed and a novel mutation (Y567X) in CLCN5 was identified. Conclusion: Hypokalemic metabolic alkalosis is a rare manifestation in Dent disease. It is speculated that Dent patients with features of Bartter syndrome are susceptible to progression to renal failure. To study this hypothesis, additional observations and long-term follow-up of such patients are necessary.
Literature
1.
go back to reference Akil I, Ozen S, Kandiloglu AR, Ersoy B (2010) A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis. Clin Exp Nephrol 14:278–282PubMedCrossRef Akil I, Ozen S, Kandiloglu AR, Ersoy B (2010) A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis. Clin Exp Nephrol 14:278–282PubMedCrossRef
2.
go back to reference Besbas N, Ozaltin F, Jeck N, Seyberth H, Ludwig M (2005) CLCN5 mutation (R347X) associated with hypokalemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent’s disease. Nephrol Dial Transplant 20:1476–1479PubMedCrossRef Besbas N, Ozaltin F, Jeck N, Seyberth H, Ludwig M (2005) CLCN5 mutation (R347X) associated with hypokalemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent’s disease. Nephrol Dial Transplant 20:1476–1479PubMedCrossRef
3.
go back to reference Bogdanovic R, Draaken M, Toromanovic A, Dordevic M, Stajic N, Ludwig M (2010) A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency. Pediatr Nephrol 25:2363–2368PubMedCrossRef Bogdanovic R, Draaken M, Toromanovic A, Dordevic M, Stajic N, Ludwig M (2010) A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency. Pediatr Nephrol 25:2363–2368PubMedCrossRef
4.
go back to reference Christensen EI, Devuyst O, Dom G, Nielsen R, Van der Smissen P, Verroust P, Leruth M, Guggino WB, Courtoy PJ (2003) Loss of chloride channel CLC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci USA 100:8472–8477PubMedCrossRef Christensen EI, Devuyst O, Dom G, Nielsen R, Van der Smissen P, Verroust P, Leruth M, Guggino WB, Courtoy PJ (2003) Loss of chloride channel CLC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci USA 100:8472–8477PubMedCrossRef
5.
go back to reference Claverie-Martin F, Ramos-Trujillo E, Garcia-Nieto V (2011) Dent’s disease: clinical features and molecular basis. Pediatr Nephrol 26:693–704PubMedCrossRef Claverie-Martin F, Ramos-Trujillo E, Garcia-Nieto V (2011) Dent’s disease: clinical features and molecular basis. Pediatr Nephrol 26:693–704PubMedCrossRef
6.
go back to reference Copelovitch L, Nash MA, Kaplan BS (2007) Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2:914–918PubMedCrossRef Copelovitch L, Nash MA, Kaplan BS (2007) Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2:914–918PubMedCrossRef
7.
go back to reference Fukushige J, Shimomura K, Ueda K (1994) Influence of upright activity on plasma rennin activity and aldosterone concentration in children. Eur J Pediatr 153:284–286PubMedCrossRef Fukushige J, Shimomura K, Ueda K (1994) Influence of upright activity on plasma rennin activity and aldosterone concentration in children. Eur J Pediatr 153:284–286PubMedCrossRef
8.
go back to reference Kaneko K, Hasui M, Hata A, Nozu K (2010) Focal segmental glomerulosclerosis in a boy with Dent-2 disease. Pediatr Nephrol 25:781–782PubMedCrossRef Kaneko K, Hasui M, Hata A, Nozu K (2010) Focal segmental glomerulosclerosis in a boy with Dent-2 disease. Pediatr Nephrol 25:781–782PubMedCrossRef
9.
go back to reference Schachter AD, Arbus GS, Alexander RJ, Balfe JW (1998) Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome. Pediatr Nephrol 12:775–777PubMedCrossRef Schachter AD, Arbus GS, Alexander RJ, Balfe JW (1998) Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome. Pediatr Nephrol 12:775–777PubMedCrossRef
10.
go back to reference Sheffer-Babila S, Chandra M, Speiser PW (2008) Growth hormone improves growth rate and preserves renal function in Dent disease. J Pediatr Endocrinol Metab 21:279–286PubMedCrossRef Sheffer-Babila S, Chandra M, Speiser PW (2008) Growth hormone improves growth rate and preserves renal function in Dent disease. J Pediatr Endocrinol Metab 21:279–286PubMedCrossRef
11.
go back to reference Su IH, Frank R, Gauthier BG, Valderrama E, Simon DB, Lifton RP, Trachtman H (2000) Bartter syndrome and focal segmental glomerulosclerosis: a possible link between two diseases. Pediatr Nephrol 14:970–972PubMedCrossRef Su IH, Frank R, Gauthier BG, Valderrama E, Simon DB, Lifton RP, Trachtman H (2000) Bartter syndrome and focal segmental glomerulosclerosis: a possible link between two diseases. Pediatr Nephrol 14:970–972PubMedCrossRef
12.
go back to reference Tosetto E, Ghiggeri GM, Emma F, Barbano G, Carrea A, Vezzoli G, Torregrossa R, Cara M, Ripanti G, Ammenti A, Peruzzi L, Murer L, Ratsch IM, Citron L, Gambaro G, D’angelo A, Anglani F (2006) Phenotypic and genetic heterogeneity in Dent’s disease—the results of an Italian collaborative study. Nephrol Dial Transplant 21:2452–2463PubMedCrossRef Tosetto E, Ghiggeri GM, Emma F, Barbano G, Carrea A, Vezzoli G, Torregrossa R, Cara M, Ripanti G, Ammenti A, Peruzzi L, Murer L, Ratsch IM, Citron L, Gambaro G, D’angelo A, Anglani F (2006) Phenotypic and genetic heterogeneity in Dent’s disease—the results of an Italian collaborative study. Nephrol Dial Transplant 21:2452–2463PubMedCrossRef
13.
go back to reference Yamazaki H, Nozu K, Narita I, Nagata M, Nozu Y, Fu XJ, Matsuo M, Iijima K, Gejyo F (2009) Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis. Pediatr Nephrol 24:415–418PubMedCrossRef Yamazaki H, Nozu K, Narita I, Nagata M, Nozu Y, Fu XJ, Matsuo M, Iijima K, Gejyo F (2009) Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis. Pediatr Nephrol 24:415–418PubMedCrossRef
Metadata
Title
A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5
Authors
Takayuki Okamoto
Toshihiro Tajima
Tomoya Hirayama
Satoshi Sasaki
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 2/2012
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-011-1578-3

Other articles of this Issue 2/2012

European Journal of Pediatrics 2/2012 Go to the issue